METiS TechBio relocates corporate headquarters to Nexxus Building Hong Kong
Biotechnology firm METiS TechBio leased office facilities in Central s Nexxus Building on 20 August 2026 supporting commercial expansion across Hong Kong s primary financial district
On August 20, 2026, METiS TechBio, a pioneering artificial intelligence-powered drug delivery biotechnology company, relocated its corporate headquarters to the Nexxus Building in Hong Kong. This move underscores the building's appeal to cutting-edge tech firms and aligns with the property's recent upgrades. Trivium Asset Management, which operates the building, has recently transformed the 23rd floor into a versatile event space, "Nexxus Hub," and subdivided the 6th floor into six smaller units to cater to a variety of business needs.
METiS TechBio's CEO, Dr. Chris Lai, expressed enthusiasm about the location, citing Central as an ideal hub for their rapid business expansion and global reach. The building, originally the headquarters of Hang Seng Bank, has been a key player in Hong Kong's financial landscape since 1962 and continues to attract global corporations and premium tenants.
Trivium Asset Management's Wilfred Ma highlighted the building's strategic location and upgraded facilities as a significant factor in METiS TechBio's decision to establish its headquarters there.
Written by urgent.news from Vietnam Investment Review's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
